While these findings attest to an injurious role of CD36, its role in monocytes and macrophages in mediating phagocytosis during the resolution phase of stroke has also been demonstrated [37], suggesting potentially beneficial aspects of CD36 signalling. This evidence concerns the gene CD36 and stroke disorder.